Case report
===========

In December 2005, an 84-year-old man was transported to the trauma unit at the Karolinska Hospital after a severe accident in which he was run over by a reversing car. At arrival his Glasgow Coma Scale score was 15 and he had multiple costa fractures and pneumothorax and was treated at the intensive care unit for 2 days and was in hospital for additional 5 days before he could be discharged.

At arrival to the emergency department it was noted that he had a scar at the left hip. He had a total hip arthroplasty at the Karolinska Hospital on May 25, 1970 and the prosthesis had worked perfectly ever since. An X-ray showed no evidence of loosening or osteolysis ([Figure 1](#f1-mder_4256_wretenberg_100708){ref-type="fig"}). The prosthesis was a McKee -- Farrar metal-on-metal cobalt-chromium alloy hip arthroplasty (Howmedica Limited, London, UK). Since we have an interest in metal-on-metal prosthesis in relation to the metal ion concentration in blood, we decided to measure the concentrations of chromium and cobalt in his blood. The analysis was made with inductively coupled plasma mass spectrometer (ICP-MS) ([@b6-mder_4256_wretenberg_100708]). The chromium concentration was 19.43 μg/L (0.05--0.48) and the cobalt concentration was 22.92 μg/L (0.03--0.8). These levels are about 40 times higher than normal. The patient was otherwise healthy with no problems from internal organs or skin. The hip was completely painless with good range of motion: flexion 85°, extension 0°, internal rotation 5°, external rotation 15°, abduction 30°, and adduction 10°. The creatinin level was slightly increased at 129 μmol/L (ref. \<100), but the patient had no clinical sign of renal failure. Other blood samples showed LPK 4.7 × 10^9^/l (ref. 3.5--8.8), T-cell count 86% (ref. 63--88), and normal levels of S-IgG, S-IgA, and S-IgM were found.

Discussion
==========

Today, the numbers of metal-on-metal implants are increasing rapidly due to the high interest in surface replacement arthroplasty. One side effect of this type of articulation is that metal ions such as cobalt, chromium, manganese, and nickel are released from such articulations and can be found in the proximity of the implant. These heavy metal ions are distributed via the blood stream to distant parenchymal organs ([@b9-mder_4256_wretenberg_100708]) and are subsequently excreted renally. The consequences of metal ion release from orthopedic implants are unclear. It is well known that ions such as nickel and chromium can induce allergic reactions. However, very few reports have shown allergic reactions from metal implants ([@b7-mder_4256_wretenberg_100708]). Several other concerns as lymphocyte-mediated osteolysis ([@b11-mder_4256_wretenberg_100708]), inhibition of osteoblast proliferation and collagen synthesis ([@b1-mder_4256_wretenberg_100708]), toxicological considerations ([@b10-mder_4256_wretenberg_100708]; [@b8-mder_4256_wretenberg_100708]) and immunological changes ([@b2-mder_4256_wretenberg_100708]) have also been raised. Several studies describe increased levels of metal ions after implantation of a metal-on-metal prosthesis (eg, [@b5-mder_4256_wretenberg_100708]; [@b4-mder_4256_wretenberg_100708]) and the increased levels have been shown to be up to 10-fold in serum. A 3-fold increase in serum cobalt 20 years after McKee--Farrar prosthesis has been found ([@b3-mder_4256_wretenberg_100708]). There are no previous case reports or studies of ion levels 37 years after metal-on-metal implantation. This case indicates that metal ion levels might rise to extreme levels in the very long term for patients with metal-on-metal articulations. Nowadays, since patients who are selected for metal-on-metal prosthesis are mostly young, this might be a future concern. For example, what will happen in cases of renal failure?

Conclusion
==========

Metal ion concentration after implantation of a metal-on-metal prosthesis can rise to extreme levels in the long run. However, this might not be associated with illness or poor hip function. On the other hand, it is a concern that must be addressed preoperatively.
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